bet9九州网址

  • <kbd id="sdring" ><rt id="sdring" ><bdo id="sdring" ></bdo></rt></kbd>
  • <source id="sdring" ></source>

    <b id="sdring" ></b>
  • <b id="sdring" ><acronym id="sdring" ><meter id="sdring" ></meter></acronym></b>

        <del id="sdring" ></del>
        Log in
        E-mail
        Password
        Remember
        Forgot password ?
        Become a member for free
        Sign up
        Sign up
        New member
        Sign up for FREE
        New customer
        Discover our services
        Settings
        Settings
        Dynamic quotes 

        MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

        News : Sectors

        Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors
        11/07TEVA PHARMACEUTICAL INDUSTRIES : Pharm says opioid settlement will not derail ability to cut debt
        RE
        11/07SAGE THERAPEUTICS, INC. : quaterly earnings release
        11/07Teva Pharmaceutical Names Eli Kalif Chief Financial Officer
        DJ
        11/07ZOETIS : Increases Earnings Guidance for 2019, Narrows Revenue Expectation
        DJ
        11/07ZOETIS : 3Q Earnings Beat Estimates
        DJ
        11/07OBSEVA : Ending Nolasiban IVF Program As Phase 3 Study Fails
        DJ
        11/06ABBVIE : Form 8.3 -
        DJ
        11/06ALLERGAN : Form 8.3 -
        DJ
        11/06ALMIRALL, S.A. : quaterly earnings release
        11/06ICU MEDICAL, INC. : quaterly earnings release
        11/06Biogen Adding Ophthalmology Biosimilars in Deal With Samsung Bioepis
        DJ
        11/06Humana Raises 2019 Earnings Outlook
        DJ
        11/06Humana Profit Rises, Beats Expectations
        DJ
        11/06CVS HEALTH : Beats Revenue Expectations, Raises Earnings Outlook
        DJ
        11/06ASTRAZENECA : Britain's AstraZeneca launches $1 billion China investment fund with CICC
        RE
        03:48aMEDICLINIC INTERNATIONAL : reports 4% rise in first-half profit
        RE
        02:48aAbbott's White To Step Down as Chief Executive -- WSJ
        DJ
        01:37aMERCK : 3Q Net Profit, Revenue Rose
        DJ
        11/13Longtime Abbott Labs CEO Miles White to Step Down in March -- 2nd Update
        DJ
        11/13Longtime Abbott Labs CEO Miles White to Step Down in March -- Update
        DJ
        11/13ALLERGAN : Form 8.3 - Allergan Plc -2-
        DJ
        11/13ALLERGAN : Form 8.3 - Allergan Plc
        DJ
        11/13MEDIATION BETWEEN BAYER, PLAINTIFFS SEEKS TO CLARIFY ALL JUSTIFIED CLAIMS : U.S. mediator
        RE
        11/13CSPC PHARMACEUTICAL GROUP LIMITED : quaterly earnings release
        11/13NETCARE LIMITED : annual earnings release
        11/13DEMANT A/S : quaterly sales release
        11/13CREDIT MARKETS : AbbVie's $30 Billion Sale of Debt Draws Strong Demand -- WSJ
        DJ
        11/12ABBVIE : Sells $30 Billion of Bonds -- 2nd Update
        DJ
        11/12CRONOS : Pot producers Cronos and Tilray report lower prices, soaring expenses
        RE
        11/12TILRAY : reports bigger loss as oversupply hits weed prices
        RE
        11/12AbbVie Prepares Large Bond Sale -- Update
        DJ
        11/12ABBVIE : Prepares Large Bond Sale to Fund Allergan Purchase
        DJ
        11/12MYLAN N : and Pfizer Say Combined -Upjohn to Be Called Viatris
        DJ
        11/12ALLERGAN : Form 8.3 - Allergan Plc
        DJ
        11/12CANTARGIA AB (PUBL) : quaterly earnings release
        11/12KARO PHARMA AB (PUBL) : quaterly earnings release
        11/12MERCK : Licenses CRISPR Gene-Editing Technology to Evotec
        DJ
        11/12ELI LILLY AND : Says Taltz Met Endpoints in Axial Spondyloarthritis Study
        DJ
        11/12GOSSAMER BIO : in Agreement with Merck for Solid Tumor Studies
        DJ
        11/12PFIZER : Xeljanz Study in Juvenile Idiopathic Arthritis Met Primary Endpoint
        DJ
        11/11MERCK AND : Gets Conditional European Commission Approval for Ebola Vaccine
        DJ
        11/11ALLERGAN : Form 8.3 -
        DJ
        11/11AURORA CANNABIS INC. : quaterly earnings release
        11/11CANOPY GROWTH CORPORATION : half-yearly earnings release
        11/11ASAHI INTECC CO., LTD. : quaterly earnings release
        11/11MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN : quaterly earnings release
        11/11J&J'S JANSSEN : Tremfya Meets Main Endpoints in Psoriatic Arthritis Studies
        DJ
        11/11ALLERGAN : Gets FDA Fast-Track, Qualified Infectious Disease Status for ATM-AVI
        DJ
        11/11BRISTOL MYERS SQUIBB : Myers Gets FDA Priority Review, Breakthrough Designation for Opdivo/Yervoy Combo
        DJ
        11/11The underlying trend is in force again
        11/11ASPEN PHARMACARE : Novartis buys Aspen's Japanese generic unit for up to 400 million euros
        RE
        11/11NOVARTIS : Sandoz generics unit buying Aspen's Japanese operations
        RE
        11/08FibroGen, AstraZeneca Up After Roxadustat Data
        DJ
        11/08ACCELERON PHARMA : Shares Gain Ground After FDA Approves Reblozyl
        DJ
        11/08CELGENE : FDA Approves Celgene's and Acceleron's Reblozyl to Treat Rare Blood Disorder
        DJ
        11/08ALLERGAN : Form 8.3 - Allergan Plc
        DJ
        11/08JOHNSON & JOHNSON : J&J's Janssen Gets Health Canada OK for Expanded Imbruvica Use
        DJ
        11/08PFIZER, MERCK KGAA : Bavencio Misses Main Endpoint in Gastric Cancer Study
        DJ
        11/08THERMO FISHER SCIENTIFIC : Board Authorizes $2.5 Billion Stock Buyback
        DJ
        11/08JOHNSON & JOHNSON : J&J's Janssen Seeks FDA OK for Expanded Imbruvica Use
        DJ
        11/08AstraZeneca Finds Increased Hemoglobinin in Roxadustat Phase 3 Trial
        DJ
        11/07TEVA PHARMACEUTICAL INDUSTRIES : High Debt, Potential Litigation Costs Face New Teva CFO
        DJ
        11/07GILEAD SCIENCES : U.S. Sues HIV Drugmaker Gilead Alleging It Infringed on PrEP Patent -- Update
        DJ
        11/07GILEAD SCIENCES : U.S. Sues HIV Drugmaker Gilead Alleging It Infringed on PrEP Patent
        DJ
        11/07PEPTIDREAM INC. : quaterly earnings release
        Discover
        07:42aALLERGAN : Exicure and Allergan Agree to Develop Hair-Loss Treatment
        DJ
        07:41aMerck, AstraZeneca Get FDA Priority Review for Selumetinib in NF1
        DJ
        06:40aCANOPY GROWTH : Pot company Canopy Growth reports bigger loss
        RE
        04:12aThe medium term resistance level limits the upside potential
        1  2  3  4  5  6  7  8  9  10Next
        bet9九州网址

            ,